Study protocol for a pragmatic cluster randomized controlled trial to improve dietary diversity and physical fitness among older people who live at home (the "ALAPAGE study").

Cluster randomized controlled trial Dietary diversity Elderly people Health education Healthy ageing Lifestyle integrated functional exercise Nutrition Physical activity Quality of life

Journal

BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548

Informations de publication

Date de publication:
04 08 2022
Historique:
received: 06 04 2022
accepted: 03 07 2022
entrez: 4 8 2022
pubmed: 5 8 2022
medline: 9 8 2022
Statut: epublish

Résumé

Diet and physical activity are key components of healthy aging. Current interventions that promote healthy eating and physical activity among the elderly have limitations and evidence of French interventions' effectiveness is lacking. We aim to assess (i) the effectiveness of a combined diet/physical activity intervention (the "ALAPAGE" program) on older peoples' eating behaviors, physical activity and fitness levels, quality of life, and feelings of loneliness; (ii) the intervention's process and (iii) its cost effectiveness. We performed a pragmatic cluster randomized controlled trial with two parallel arms (2:1 ratio) among people ≥60 years old who live at home in southeastern France. A cluster consists of 10 people participating in a "workshop" (i.e., a collective intervention conducted at a local organization). We aim to include 45 workshops randomized into two groups: the intervention group (including 30 workshops) in the ALAPAGE program; and the waiting-list control group (including 15 workshops). Participants (expected total sample size: 450) will be recruited through both local organizations' usual practices and an innovative active recruitment strategy that targets hard-to-reach people. We developed the ALAPAGE program based on existing workshops, combining a participatory and a theory-based approach. It includes a 7-week period with weekly collective sessions supported by a dietician and/or an adapted physical activity professional, followed by a 12-week period of post-session activities without professional supervision. Primary outcomes are dietary diversity (calculated using two 24-hour diet recalls and one Food Frequency Questionnaire) and lower-limb muscle strength (assessed by the 30-second chair stand test from the Senior Fitness Test battery). Secondary outcomes include consumption frequencies of main food groups and water/hot drinks, other physical fitness measures, overall level of physical activity, quality of life, and feelings of loneliness. Outcomes are assessed before the intervention, at 6 weeks and 3 months later. The process evaluation assesses the fidelity, dose, and reach of the intervention as its causal mechanisms (quantitative and qualitative data). This study aims to improve healthy aging while limiting social inequalities. We developed and evaluated the ALAPAGE program in partnership with major healthy aging organizations, providing a unique opportunity to expand its reach. ClinicalTrials.gov Identifier: NCT05140330 , December 1, 2021. Version 3.0 (November 5, 2021).

Sections du résumé

BACKGROUND
Diet and physical activity are key components of healthy aging. Current interventions that promote healthy eating and physical activity among the elderly have limitations and evidence of French interventions' effectiveness is lacking. We aim to assess (i) the effectiveness of a combined diet/physical activity intervention (the "ALAPAGE" program) on older peoples' eating behaviors, physical activity and fitness levels, quality of life, and feelings of loneliness; (ii) the intervention's process and (iii) its cost effectiveness.
METHODS
We performed a pragmatic cluster randomized controlled trial with two parallel arms (2:1 ratio) among people ≥60 years old who live at home in southeastern France. A cluster consists of 10 people participating in a "workshop" (i.e., a collective intervention conducted at a local organization). We aim to include 45 workshops randomized into two groups: the intervention group (including 30 workshops) in the ALAPAGE program; and the waiting-list control group (including 15 workshops). Participants (expected total sample size: 450) will be recruited through both local organizations' usual practices and an innovative active recruitment strategy that targets hard-to-reach people. We developed the ALAPAGE program based on existing workshops, combining a participatory and a theory-based approach. It includes a 7-week period with weekly collective sessions supported by a dietician and/or an adapted physical activity professional, followed by a 12-week period of post-session activities without professional supervision. Primary outcomes are dietary diversity (calculated using two 24-hour diet recalls and one Food Frequency Questionnaire) and lower-limb muscle strength (assessed by the 30-second chair stand test from the Senior Fitness Test battery). Secondary outcomes include consumption frequencies of main food groups and water/hot drinks, other physical fitness measures, overall level of physical activity, quality of life, and feelings of loneliness. Outcomes are assessed before the intervention, at 6 weeks and 3 months later. The process evaluation assesses the fidelity, dose, and reach of the intervention as its causal mechanisms (quantitative and qualitative data).
DISCUSSION
This study aims to improve healthy aging while limiting social inequalities. We developed and evaluated the ALAPAGE program in partnership with major healthy aging organizations, providing a unique opportunity to expand its reach.
TRIAL REGISTRATION
ClinicalTrials.gov Identifier: NCT05140330 , December 1, 2021.
PROTOCOL VERSION
Version 3.0 (November 5, 2021).

Identifiants

pubmed: 35927684
doi: 10.1186/s12877-022-03260-8
pii: 10.1186/s12877-022-03260-8
pmc: PMC9351201
doi:

Banques de données

ClinicalTrials.gov
['NCT05140330']

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

643

Informations de copyright

© 2022. The Author(s).

Références

J Nutr Educ Behav. 2020 Feb;52(2):180-186
pubmed: 31540863
Addiction. 2016 Jan;111(1):94-106
pubmed: 26234629
BMC Geriatr. 2016 Nov 17;16(1):187
pubmed: 27855641
J Nutr Health Aging. 2019;23(1):89-95
pubmed: 30569075
BMC Public Health. 2017 Apr 21;17(1):349
pubmed: 28431552
J Am Med Dir Assoc. 2020 Aug;21(8):1065-1072.e3
pubmed: 31948853
J Nutr. 2007 Mar;137(3):647-51
pubmed: 17311954
Br J Nutr. 2018 Sep;120(5):549-556
pubmed: 29987992
J Nutr. 2001 Aug;131(8):2192-6
pubmed: 11481416
Clin Rehabil. 2008 Jun;22(6):493-502
pubmed: 18511529
J Nutr Health Aging. 2018;22(3):451-456
pubmed: 29484361
Geriatr Gerontol Int. 2017 Jun;17(6):937-944
pubmed: 27380888
Soc Sci Med. 2014 Feb;102:83-93
pubmed: 24565145
BMC Geriatr. 2013 Jan 23;13:8
pubmed: 23343312
Trials. 2020 Jul 11;21(1):637
pubmed: 32653012
N Engl J Med. 2008 Feb 14;358(7):661-3
pubmed: 18272889
Med Sci (Paris). 2004 Mar;20(3):363-6
pubmed: 15067584
Phys Sportsmed. 2009 Jun;37(2):127-35
pubmed: 20048519
Rev Bras Fisioter. 2010 May-Jun;14(3):229-36
pubmed: 20730368
Curr Dev Nutr. 2020 May 28;4(7):nzaa099
pubmed: 32666032
J Am Geriatr Soc. 2018 Sep;66(9):1721-1729
pubmed: 30019768
Maturitas. 2015 Dec;82(4):387-93
pubmed: 26316025
Nutrients. 2018 Jan 26;10(2):
pubmed: 29373529
BMJ. 2016 Aug 16;354:i4291
pubmed: 27530617
Cochrane Database Syst Rev. 2011 Nov 09;(11):CD004963
pubmed: 22071817
J Am Geriatr Soc. 2007 May;55(5):674-83
pubmed: 17493186
J Am Med Dir Assoc. 2017 Feb 1;18(2):169-175
pubmed: 27847264
Transl Behav Med. 2020 Oct 12;10(5):1098-1109
pubmed: 33044541
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
BMC Geriatr. 2019 Jul 26;19(1):197
pubmed: 31349800
Int J Public Health. 2013 Jun;58(3):449-58
pubmed: 23111370
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
Am J Clin Nutr. 2020 Apr 1;111(4):877-883
pubmed: 32091575
Br J Nutr. 2014 Nov 14;112(9):1562-74
pubmed: 25242619
Nutr J. 2011 Nov 14;10:123
pubmed: 22078240
Span J Psychol. 2012 Jul;15(2):801-16
pubmed: 22774454
Soc Sci Med. 2012 Aug;75(4):659-67
pubmed: 22365936
Sensors (Basel). 2021 Aug 23;21(16):
pubmed: 34451115
BMJ. 2013 Jan 08;346:e7586
pubmed: 23303884
Clin Nutr. 2018 Aug;37(4):1293-1298
pubmed: 28629899
Int J Nurs Stud. 2018 Mar;79:86-93
pubmed: 29220738
J Gerontol A Biol Sci Med Sci. 2005 May;60(5):613-21
pubmed: 15972614
Lancet Public Health. 2019 Mar;4(3):e159-e167
pubmed: 30851869
Public Health. 2013 Sep;127(9):844-53
pubmed: 23148890
J Sci Med Sport. 2020 Mar;23(3):276-282
pubmed: 31615727
J Clin Epidemiol. 1998 Nov;51(11):1171-8
pubmed: 9817135
Health Educ Behav. 2020 Feb;47(1):47-56
pubmed: 31933395
J Am Med Dir Assoc. 2021 Apr;22(4):792-802.e2
pubmed: 33548182
Adv Nutr. 2021 Oct 1;12(5):1659-1672
pubmed: 33684194
BMJ. 2012 Aug 07;345:e4547
pubmed: 22872695
BMJ. 2015 May 08;350:h2147
pubmed: 25956159
Rehabil Res Pract. 2018 Jun 19;2018:5230971
pubmed: 30018825

Auteurs

Aurélie Bocquier (A)

ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France. aurelie.bocquier@univ-lorraine.fr.
Université de Lorraine, APEMAC, F-54000, Nancy, France. aurelie.bocquier@univ-lorraine.fr.

Anne-Fleur Jacquemot (AF)

ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France.
Bordeaux Population Health Research Center, University of Bordeaux, Inserm, UMR 1219, F-33000, Bordeaux, France.

Christophe Dubois (C)

Trophis, 13170, Les Pennes Mirabeau, France.

Hélène Tréhard (H)

ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France.
Aix Marseille Univ, IRD, INSERM, SESSTIM, Aix Marseille Institute of Public Health, ISSPAM, Marseille, France.

Chloé Cogordan (C)

ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France.

Gwenaëlle Maradan (G)

ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France.

Sébastien Cortaredona (S)

ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France.
Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.
IHU-Méditerranée Infection, Marseille, France.

Lisa Fressard (L)

ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France.
Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.
IHU-Méditerranée Infection, Marseille, France.

Bérengère Davin-Casalena (B)

ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France.

Agnès Vinet (A)

Avignon Université, UPR EA4278, F-84000, Avignon, France.

Pierre Verger (P)

ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France.
Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.
IHU-Méditerranée Infection, Marseille, France.

Nicole Darmon (N)

MoISA, Université de Montpellier, CIHEAM-IAMM, CIRAD, INRAE, Institut Agro, IRD, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH